Antidepressant Dispensing to US Adolescents and Young Adults: 2016–2022 | Citedby Results | Pediatrics | American Academy of Pediatrics

Skip to Main Content

Skip Nav Destination

Antidepressant Dispensing to US Adolescents and Young Adults: 2016–2022

Pediatrics (2024) 153 (3): e2023064245.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Impact of COVID-19 pandemic on prescription of psychotropic medications in the Italian paediatric population during 2020

Francesca Gallinella
Francesco Trotta
Filomena Fortinguerra

Italian Journal of Pediatrics (2024) 50 (1)

COVID-19 and fear of death: Has the pandemic changed our death orientation?

Rakesh Khanna

Journal of Indira Gandhi Institute of Medical Sciences (2024) 10 (2): 93.

Incident Psychotropic Medication Use Among US Commercially Insured Children and Adolescents from 2019 to 2022

Haeyoung Lee
Alejandro Amill-Rosario
Gloria Reeves
Susan dosReis

Journal of Child and Adolescent Psychopharmacology (2024) 34 (9): 414.

The Declining Mental Health of the Young and the Global Disappearance of the Hump Shape in Age in Unhappiness

David G. Blanchflower
Alex Bryson
Xiaowei Xu

SSRN Electronic Journal (2024)

Antidepressant Prescriptions and Mental Health

Arwa K. Nasir
Laeth S. Nasir

Pediatrics (2024) 153 (3)

Selective Serotonin Reuptake Inhibitor Prescribing Within an Integrated Pediatric Primary Care Behavioral Health Program

Louis Vernacchio
Jonas Bromberg
Emily T. Correa
Margaret Fry
Heather J. Walter

Academic Pediatrics 102596.

Invisible Victims and the Case for OTC SSRIs

Jacob M. Appel

Cambridge Quarterly of Healthcare Ethics 1.

Characteristics Associated With Mental Health Treatment Prior to Suicide Among Youth in the United States

Cynthia A. Fontanella
Xueting Xia
John V. Campo
Danielle L. Steelesmith
Jeffrey A. Bridge
Donna A. Ruch

Journal of the American Academy of Child & Adolescent Psychiatry (2024)